Erythropoietin: High profile, high scrutiny

被引：28

作者：

Crawford, Jeffrey ^{[1
]}

机构：

[1] Duke Univ, Dept Med, Durham, NC 27706 USA

[2] Duke Univ, Duke Comprehens Canc Ctr, Durham, NC USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 09期

关键词：

D O I：

10.1200/JCO.2006.08.8153

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1021 / 1023

页数：3

共 23 条

[1] Recombinant human erythropoietin and overall survival in cancer patients: Results of a comprehensive meta-analysis [J].

Bohlius, J ;

Langensiepen, S ;

Schwarzer, G ;

Seidenfeld, J ;

Piper, M ;

Bennett, C ;

Engert, A .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (07) :489-498

[2] Recombinant human erythropoietins and cancer patients: Updated meta-analysis of 57 studies including 9353 patients [J].

Bohlius, Julia ;

Wilson, Jayne ;

Seidenfeld, Jerome ;

Piper, Margaret ;

Schwarzer, Guido ;

Sandercock, Josie ;

Trelle, Sven ;

Weingart, Olaf ;

Bayliss, Sue ;

Djulbegovic, Benjamin ;

Bennett, Charles L. ;

Langensiepen, Simon ;

Hyde, Chris ;

Engert, Andreas .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (10) :708-714

[3]

Cella D, 1998, SEMIN ONCOL, V25, P43

[4]

CRAWFORD J, 2002, CANCER, V94, P888

[5] A Randomized trial comparing immediate versus delayed treatment of anemia with once-weekly epoetin alfa in patients with non-small cell lung cancer scheduled to receive first-line chemotherapy [J].

Crawford, Jeffrey ;

Robert, Francisco ;

Perry, Michael C. ;

Belani, Chandra ;

Williams, Denise .

JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (03) :210-220

[6]

Crawford Jeffrey, 2006, Oncology (Williston Park), V20, P39

[7] Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study [J].

Demetri, GD ;

Kris, M ;

Wade, J ;

Degos, L ;

Cella, D .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3412-3425

[8] CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL [J].

ESCHBACH, JW ;

EGRIE, JC ;

DOWNING, MR ;

BROWNE, JK ;

ADAMSON, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) :73-78

[9] Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing [J].

Gabrilove, JL ;

Cleeland, CS ;

Livingston, RB ;

Sarokhan, B ;

Winer, E ;

Einhorn, LH .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) :2875-2882

[10] Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice [J].

Glaspy, J ;

Bukowski, R ;

Steinberg, D ;

Taylor, C ;

Tchekmedyian, S ;

VadhanRaj, S .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :1218-1234

← 1 2 3 →